388 related articles for article (PubMed ID: 23746384)
1. Clinical value of T2-weighted imaging combined with diffusion-weighted imaging in preoperative T staging of urinary bladder cancer: a large-scale, multiobserver prospective study on 3.0-T MRI.
Wu LM; Chen XX; Xu JR; Zhang XF; Suo ST; Yao QY; Fan Y; Hu J
Acad Radiol; 2013 Aug; 20(8):939-46. PubMed ID: 23746384
[TBL] [Abstract][Full Text] [Related]
2. Diffusion-weighted magnetic resonance imaging combined with T2-weighted images in the detection of small breast cancer: a single-center multi-observer study.
Wu LM; Chen J; Hu J; Gu HY; Xu JR; Hua J
Acta Radiol; 2014 Feb; 55(1):24-31. PubMed ID: 23878358
[TBL] [Abstract][Full Text] [Related]
3. Urinary bladder cancer: diffusion-weighted MR imaging--accuracy for diagnosing T stage and estimating histologic grade.
Takeuchi M; Sasaki S; Ito M; Okada S; Takahashi S; Kawai T; Suzuki K; Oshima H; Hara M; Shibamoto Y
Radiology; 2009 Apr; 251(1):112-21. PubMed ID: 19332849
[TBL] [Abstract][Full Text] [Related]
4. Preoperative T staging of urinary bladder cancer: does diffusion-weighted MRI have supplementary value?
Watanabe H; Kanematsu M; Kondo H; Goshima S; Tsuge Y; Onozuka M; Moriyama N
AJR Am J Roentgenol; 2009 May; 192(5):1361-6. PubMed ID: 19380561
[TBL] [Abstract][Full Text] [Related]
5. T staging of rectal cancer: accuracy of diffusion-weighted imaging compared with T2-weighted imaging on 3.0 tesla MRI.
Feng Q; Yan YQ; Zhu J; Xu JR
J Dig Dis; 2014 Apr; 15(4):188-94. PubMed ID: 24373561
[TBL] [Abstract][Full Text] [Related]
6. Preoperative T staging of urinary bladder cancer: efficacy of stalk detection and diagnostic performance of diffusion-weighted imaging at 3T.
Ohgiya Y; Suyama J; Sai S; Kawahara M; Takeyama N; Ohike N; Sasamori H; Munechika J; Saiki M; Onoda Y; Hirose M; Gokan T
Magn Reson Med Sci; 2014; 13(3):175-81. PubMed ID: 24990469
[TBL] [Abstract][Full Text] [Related]
7. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging for predicting tumor clearance of the mesorectal fascia after neoadjuvant chemotherapy and radiation therapy.
Park MJ; Kim SH; Lee SJ; Jang KM; Rhim H
Radiology; 2011 Sep; 260(3):771-80. PubMed ID: 21846762
[TBL] [Abstract][Full Text] [Related]
8. Combined T2-weighted and diffusion-weighted MRI for diagnosis of urinary bladder invasion in patients with prostate carcinoma.
Ren J; Huan Y; Li F; Wang H; Ge Y; Chang Y; Yin H; Sun L
J Magn Reson Imaging; 2009 Aug; 30(2):351-6. PubMed ID: 19591203
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection--a multireader study.
Lim HK; Kim JK; Kim KA; Cho KS
Radiology; 2009 Jan; 250(1):145-51. PubMed ID: 19017927
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined.
Chen M; Dang HD; Wang JY; Zhou C; Li SY; Wang WC; Zhao WF; Yang ZH; Zhong CY; Li GZ
Acta Radiol; 2008 Jun; 49(5):602-10. PubMed ID: 18568549
[TBL] [Abstract][Full Text] [Related]
11. Non-contrast magnetic resonance imaging for bladder cancer: fused high b value diffusion-weighted imaging and T2-weighted imaging helps evaluate depth of invasion.
Lee M; Shin SJ; Oh YT; Jung DC; Cho NH; Choi YD; Park SY
Eur Radiol; 2017 Sep; 27(9):3752-3758. PubMed ID: 28168374
[TBL] [Abstract][Full Text] [Related]
12. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
Xu PJ; Yan FH; Wang JH; Lin J; Ji Y
J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186
[TBL] [Abstract][Full Text] [Related]
13. Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer.
Haider MA; van der Kwast TH; Tanguay J; Evans AJ; Hashmi AT; Lockwood G; Trachtenberg J
AJR Am J Roentgenol; 2007 Aug; 189(2):323-8. PubMed ID: 17646457
[TBL] [Abstract][Full Text] [Related]
14. Rectal cancer: MR imaging in local staging--is gadolinium-based contrast material helpful?
Vliegen RF; Beets GL; von Meyenfeldt MF; Kessels AG; Lemaire EE; van Engelshoven JM; Beets-Tan RG
Radiology; 2005 Jan; 234(1):179-88. PubMed ID: 15550372
[TBL] [Abstract][Full Text] [Related]
15. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
[TBL] [Abstract][Full Text] [Related]
16. Initial experience of diffusion-weighted magnetic resonance imaging to assess therapeutic response to induction chemoradiotherapy against muscle-invasive bladder cancer.
Yoshida S; Koga F; Kawakami S; Ishii C; Tanaka H; Numao N; Sakai Y; Saito K; Masuda H; Fujii Y; Kihara K
Urology; 2010 Feb; 75(2):387-91. PubMed ID: 19914691
[TBL] [Abstract][Full Text] [Related]
17. Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3T diffusion-weighted MRI.
Kim CK; Park BK; Lee HM
J Magn Reson Imaging; 2009 Feb; 29(2):391-7. PubMed ID: 19161194
[TBL] [Abstract][Full Text] [Related]
18. Nonmuscle-invasive and Muscle-invasive Urinary Bladder Cancer: Image Quality and Clinical Value of Reduced Field-of-view Versus Conventional Single-shot Echo-planar Imaging DWI.
Wang Y; Li Z; Meng X; Hu X; Shen Y; Morelli J; Lin H; Zhang Z; Hu D
Medicine (Baltimore); 2016 Mar; 95(10):e2951. PubMed ID: 26962794
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of diffusion-weighted imaging in the localization of prostate cancer.
Kajihara H; Hayashida Y; Murakami R; Katahira K; Nishimura R; Hamada Y; Kitani K; Kitaoka M; Suzuki Y; Kitajima M; Hirai T; Morishita S; Awai K; Yamashita Y
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):399-403. PubMed ID: 19019564
[TBL] [Abstract][Full Text] [Related]
20. Multiparametric 3-T MRI for differentiating low-versus high-grade and category T1 versus T2 bladder urothelial carcinoma.
Wang HJ; Pui MH; Guo Y; Li SR; Guan J; Zhang XL; Cai HS
AJR Am J Roentgenol; 2015 Feb; 204(2):330-4. PubMed ID: 25615755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
